<p>Non-specific binding was determined in the presence of 10 µM methyllycaconitine (MLA). Data shown are the average±SEM of 3 separate experiments. A. Raw saturation binding data shows total, nonspecific, and specific binding for [<sup>125</sup>I]α-BTX to α7-nAChR in this cell line. B. Specific binding of [<sup>125</sup>I]α-BTX to α7-nAChR in fmol/mg protein with Scatchard analysis. C. Comparison of maximal specific [<sup>125</sup>I]α-BTX binding displacement by AChE peptides T14 and T30, as compared with known α7-nAChR antagonists and agonists. ACh = acetylcholine. D. Maximal specific [<sup>125</sup>I]α-BTX binding displacement by control peptides, full length T-AChE, and truncated AChE (T548). E. Displacement binding profiles for AChE C-t...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>Cch binding to wild-type m1 receptor (A) and <i>in vitro</i> labeled M1S2-FlAsH (B) after their r...
Binding kinetics of drugs is increasingly recognized to be important for their in vivo efficacy and ...
<p>Data shown are the average±SEM of 2 separate experiments each performed in triplicate.</p
<p>Data shown are the combined results of a minimum of 2 experiments each performed in triplicate an...
<p>Summary of saturation binding parameters showing the effects of chronic T-AChE peptide treatment ...
<p>All experiments were performed a minimum of 2 times. A. Protein levels as assessed in total cell ...
The effects of structurally diverse agonists were assessed on receptor-mediated activation of G-prot...
<p>(C) Specific binding of <sup>125</sup>I-CaIX-P1-4-10 on SKRC 52 cells. Non specific binding was d...
<p>GAPDH expression was used as an internal standard. Gels shown are representative results of exper...
<p>A) FITC labeled AChR-alpha subunit peptide binding to total myasthenic PBMC (0.44%), B) Excess un...
Binding kinetics of drugs is increasingly recognized to be important for their in vivo efficacy and ...
The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) w...
<p>A. Binding of <sup>125</sup>I-ProTx-II (1.5 nM) to Na<sub>V</sub>1.7 HEK293 but not parental cell...
<p>A. Cch binding (filled circle) and Cch-driven FRET changes (open circle) were measured using memb...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>Cch binding to wild-type m1 receptor (A) and <i>in vitro</i> labeled M1S2-FlAsH (B) after their r...
Binding kinetics of drugs is increasingly recognized to be important for their in vivo efficacy and ...
<p>Data shown are the average±SEM of 2 separate experiments each performed in triplicate.</p
<p>Data shown are the combined results of a minimum of 2 experiments each performed in triplicate an...
<p>Summary of saturation binding parameters showing the effects of chronic T-AChE peptide treatment ...
<p>All experiments were performed a minimum of 2 times. A. Protein levels as assessed in total cell ...
The effects of structurally diverse agonists were assessed on receptor-mediated activation of G-prot...
<p>(C) Specific binding of <sup>125</sup>I-CaIX-P1-4-10 on SKRC 52 cells. Non specific binding was d...
<p>GAPDH expression was used as an internal standard. Gels shown are representative results of exper...
<p>A) FITC labeled AChR-alpha subunit peptide binding to total myasthenic PBMC (0.44%), B) Excess un...
Binding kinetics of drugs is increasingly recognized to be important for their in vivo efficacy and ...
The interaction of the agonist JN403 with the human (h) α7 nicotinic acetylcholine receptor (AChR) w...
<p>A. Binding of <sup>125</sup>I-ProTx-II (1.5 nM) to Na<sub>V</sub>1.7 HEK293 but not parental cell...
<p>A. Cch binding (filled circle) and Cch-driven FRET changes (open circle) were measured using memb...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>Cch binding to wild-type m1 receptor (A) and <i>in vitro</i> labeled M1S2-FlAsH (B) after their r...
Binding kinetics of drugs is increasingly recognized to be important for their in vivo efficacy and ...